Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Obesity and T1D : Overweight and obesity are increasingly recognized as significant issues in T1D management as they can exacerbate insulin resistance and cardiovascular risk
Mounjaro is licensed solely for type 2 diabetes management, and whilst preclinical research suggests potential neuroprotective properties of incretin-based therapies, dedicated human trials for Mounjaro and cognitive health are lacking
These drugs should not be used in those with a family history of medullary thyroid cancer or a history of pancreatitis
Recipient factors in faecal microbiota transplantation: one stool does not fit all
Long-term success strategy : Our team works with you to develop sustainable habits for maintaining results, whether you continue medication long-term or eventually discontinue it
Lack of weight loss does not indicate safety concerns
